{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-20",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "city": "New York",
      "advisory_committee_description": "Clinical Chemistry",
      "address_1": "1460 Broadway",
      "address_2": "",
      "statement_or_summary": "",
      "product_code": "QWZ",
      "openfda": {
        "registration_number": [
          "3018739912"
        ],
        "fei_number": [
          "3018739912"
        ],
        "device_name": "Prognostic Test For Assessment Of Chronic Kidney Disease Progression",
        "medical_specialty_description": "Clinical Chemistry",
        "regulation_number": "862.1223",
        "device_class": "2"
      },
      "zip_code": "10036",
      "applicant": "Renalytix Ai, Inc.",
      "decision_date": "2023-06-29",
      "decision_code": "DENG",
      "country_code": "US",
      "device_name": "KidneyIntelX.dkd",
      "advisory_committee": "CH",
      "contact": "Joe  Hutson",
      "expedited_review_flag": "",
      "k_number": "DEN200052",
      "state": "NY",
      "date_received": "2020-08-26",
      "review_advisory_committee": "CH",
      "postal_code": "10036",
      "decision_description": "Unknown",
      "clearance_type": "Direct"
    }
  ]
}